Metagenics, FTC settle Bone Builder supplement claims case in final consent agreement.
This article was originally published in The Tan Sheet
Executive Summary
METAGENICS, FTC SETTLE BONE BUILDER CLAIMS CASE in a final consent order approved in a 3-0 vote by the Federal Trade Commission. One commissioner member abstained. The commission announced Oct. 31 that it has settled its action against Metagenics, doing business as Ethical Nutrients, related to "effectiveness" claims made for the Bone Builder calcium supplement. The case was contentious at times and the settlement is the result of extended discussion between the company and the agency.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning